- Ventricular Assist Devices (VDS)
- External Ventricular Assist Devices
- Left Ventricular Assist Devices (LVDS)
- Biventricular Assist Devices
- Right Ventricular Assist Devices
- Intra-Aortic Balloon Pumps
- Total Artificial Heart
Cardiac Assist Devices Market size was valued at USD 2.7 billion in 2022 and is poised to grow at a CAGR of 13.6% from 2023 to 2029. Cardiac Assist Devices Market are mechanical pumps, which are used to support or replace the blood flow in weak cardiac function people and patients with heart failure. These are implantable devices and can be used temporarily to help the heart rate and blood flow. The global cardiac assist devices market is expected to grow at a significant rate owing to an increase in cases of heart failure around the world. Cardiac assist devices are one of the promising treatment options for heart failure patients. Market players are focused on vertical integration in order to develop innovative products.
Cardiac Assist Devices Market Key Developments:
- In September 2017, Abiomed Inc. reciveed U.S. FDA pre-market approval (PMA) for the percutaneous temporary ventricular support device Impella RP heart pump.
- In October 2015, St. Jude Medical Inc. received CE mark approval for its left ventricular assist system (LVAS), HeratMate
Cardiac Assist Devices Market Summary
Study Period
2023-29
Base Year
2022
CAGR
13.6%
Largest Market
North America
Fastest Growing Market
North America
Cardiac Assist Devices Market Dynamics
Rising prevalence of cardiac disorders, surge in geriatric population and technological developments in cardiac assist devices, which minimize the chances of infection and improved efficiency enables attract demand for cardiac assist devices. In addition, rising number of cases of heart failure and shortage of donors for late-stage heart failure patients expected to boost the cardiac assist devices market during the forecast period. However, factors such as availability of alternative treatment options such as pacemakers and heart transplantation expected to hinder the market growth. Furthermore chances of infection, high cost of devices and stringent regulatory procedures expected to act as restraints for the growth of the cardiac assist devices market over the forecast period.
North-America Got Significant Share
Cardiac Assist Devices Market Regional Analysis
Global cardiac assist devices market is segmented into following regions, viz. North America, Asia-Pacific, Latin America, Middle East & Africa, and Europe. North America is expected to be major market for cardiac assist devices owing to factors such as growing awareness in patients about the cardiac assist devices, well-established healthcare infrastructure and favourable reimbursement policies. Europe cardiac assist devices market expected to grow at significant rates owing to increase in growing heart-related diseases and rising geriatric population. Asia-Pacific expected to grow at notable rates owing to developing healthcare infrastructure and growing awareness in patients.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Cardiac Assist Devices Market Segmentation
By Product Type
By Flow Rate
- Continuous Flow
- Pulsatile
By End-user
- Hospitals
- Ambulatory Surgical Centres
- Others
Frequently Asked Questions
The cardiac assist devices market size was valued at USD 2.7 billion in 2022
The cardiac assist devices market key players are: Calon Cardio-Technology Ltd. (UK) SynCardia Systems, Inc. (U.S.) Medtronic (U.S.) Berlin Heart GmbH (Germany) CHF Solutions, Inc. (U.S.) Teleflex Incorporated (U.S.) MAQUET GmbH & Co. (Germany) Abiomed (U.S.) Abbot Laboratories (U.S.)
The cardiac assist devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Cardiac Assist Devices Market Introduction |
| 2.1.Global Cardiac Assist Devices Market - Taxonomy |
| 2.2.Global Cardiac Assist Devices Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2. Flow Rate |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Cardiac Assist Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Cardiac Assist Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Cardiac Assist Devices Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Ventricular Assist Devices (VDS) |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. External Ventricular Assist Devices |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Left Ventricular Assist Devices (LVDS) |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Biventricular Assist Devices |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Right Ventricular Assist Devices |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Intra-Aortic Balloon Pumps |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Total Artificial Heart |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6. Global Cardiac Assist Devices Market By Flow Rate, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Continuous Flow |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pulsatile |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Cardiac Assist Devices Market By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centres |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Cardiac Assist Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Cardiac Assist Devices Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Ventricular Assist Devices (VDS) |
| 9.1.2.External Ventricular Assist Devices |
| 9.1.3.Left Ventricular Assist Devices (LVDS) |
| 9.1.4.Biventricular Assist Devices |
| 9.1.5.Right Ventricular Assist Devices |
| 9.1.6.Intra-Aortic Balloon Pumps |
| 9.1.7.Total Artificial Heart |
| 9.2. Flow Rate Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Continuous Flow |
| 9.2.2.Pulsatile |
| 9.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centres |
| 9.3.3.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Cardiac Assist Devices Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Ventricular Assist Devices (VDS) |
| 10.1.2.External Ventricular Assist Devices |
| 10.1.3.Left Ventricular Assist Devices (LVDS) |
| 10.1.4.Biventricular Assist Devices |
| 10.1.5.Right Ventricular Assist Devices |
| 10.1.6.Intra-Aortic Balloon Pumps |
| 10.1.7.Total Artificial Heart |
| 10.2. Flow Rate Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Continuous Flow |
| 10.2.2.Pulsatile |
| 10.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centres |
| 10.3.3.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Cardiac Assist Devices Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Ventricular Assist Devices (VDS) |
| 11.1.2.External Ventricular Assist Devices |
| 11.1.3.Left Ventricular Assist Devices (LVDS) |
| 11.1.4.Biventricular Assist Devices |
| 11.1.5.Right Ventricular Assist Devices |
| 11.1.6.Intra-Aortic Balloon Pumps |
| 11.1.7.Total Artificial Heart |
| 11.2. Flow Rate Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Continuous Flow |
| 11.2.2.Pulsatile |
| 11.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centres |
| 11.3.3.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Cardiac Assist Devices Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Ventricular Assist Devices (VDS) |
| 12.1.2.External Ventricular Assist Devices |
| 12.1.3.Left Ventricular Assist Devices (LVDS) |
| 12.1.4.Biventricular Assist Devices |
| 12.1.5.Right Ventricular Assist Devices |
| 12.1.6.Intra-Aortic Balloon Pumps |
| 12.1.7.Total Artificial Heart |
| 12.2. Flow Rate Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Continuous Flow |
| 12.2.2.Pulsatile |
| 12.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centres |
| 12.3.3.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Cardiac Assist Devices Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Ventricular Assist Devices (VDS) |
| 13.1.2.External Ventricular Assist Devices |
| 13.1.3.Left Ventricular Assist Devices (LVDS) |
| 13.1.4.Biventricular Assist Devices |
| 13.1.5.Right Ventricular Assist Devices |
| 13.1.6.Intra-Aortic Balloon Pumps |
| 13.1.7.Total Artificial Heart |
| 13.2. Flow Rate Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Continuous Flow |
| 13.2.2.Pulsatile |
| 13.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centres |
| 13.3.3.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Calon Cardio-Technology Ltd. (UK) |
| 14.2.2.SynCardia Systems, Inc. (U.S.) |
| 14.2.3.Medtronic (U.S.) |
| 14.2.4.Berlin Heart GmbH (Germany) |
| 14.2.5.CHF Solutions, Inc. (U.S.) |
| 14.2.6.Teleflex Incorporated (U.S.) |
| 14.2.7.MAQUET GmbH & Co. (Germany) |
| 14.2.8.Abiomed (U.S.) |
| 14.2.9.Abbot Laboratories (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Calon Cardio-Technology Ltd. (UK)
- SynCardia Systems, Inc. (U.S.)
- Medtronic (U.S.)
- Berlin Heart GmbH (Germany)
- CHF Solutions, Inc. (U.S.)
- Teleflex Incorporated (U.S.)
- MAQUET GmbH & Co. (Germany)
- Abiomed (U.S.)
- Abbot Laboratories (U.S.)